Skip to content

Edoxaban

Published: August 9, 2026Updated: August 9, 2026

Savaysa (edoxaban) is a prescription anticoagulant medication used to reduce the risk of blood clots, stroke, and systemic embolism. It is primarily prescribed for patients with non-valvular atrial fibrillation and for treating deep vein thrombosis (DVT) or pulmonary embolism (PE).

Quick summary

Savaysa is a blood thinner used to prevent strokes and treat dangerous blood clots.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 9, 2026Editorial policy

Key facts at a glance

RxNorm
1599544
Generic
Savaysa
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Savaysa is FDA-approved for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Savaysa is a direct factor Xa inhibitor that works by blocking the activity of factor Xa, an enzyme essential for the formation of blood clots. By inhibiting this clotting factor, it helps prevent the conversion of prothrombin to thrombin, reducing the blood's ability to clot.

Savaysa carries a boxed warning for increased risk of clotting and bleeding events when discontinuing abruptly. Patients should not stop taking this medication without medical supervision. It may increase the risk of bleeding, and patients should be monitored for signs of hemorrhage. Not recommended for patients with mechanical heart valves or moderate-to-severe mitral stenosis. Avoid use with concurrent P-gp inhibitors in patients with atrial fibrillation.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy